Drrx stock forecast.

View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.DURECT Corporation Stock Forecast. The DURECT Corporation Stock Prediction is based on short term trend analysis and is best used for short term swing traders or day traders rather than long term investors.. Get DRRX Trend Analysis DRRX Stock Analysis. DRRX is currently in a downtrend. DRRX is down -4.27% on 10/27/23 and has lost a …Durect DRRX is set to give its latest quarterly ... New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. DURECT (DRRX) Stock Forecast & Price Target $0.64 +0.01 (+1.03%) (As of 02:51 PM ET) Compare Today's Range $0.59 $0.65 50-Day Range $0.53 $2.98 52 …Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...Their DRRX share price targets range from $27.00 to $41.00. On average, they expect the company's stock price to reach $34.25 in the next twelve months. This suggests a possible upside of 5,194.5% from the stock's current price. View analysts price targets for DRRX or view top-rated stocks among Wall Street analysts. You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.DURECT Corporation (DRRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock DURECT Corporation | Nasdaq: DRRX | Nasdaq. 814c7.BI6jUPhZQxP2Us-zYE_8YwyJgJUUYh28OS76qNcwmk4.bt2SM58MJz61Cvb7TQevD0X7 …

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year.

Nov 14, 2023 · Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.

DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...View more. Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.DIRTT Environmental Solutions Ltd. (DRTT) share price prediction for 2023, 2024, 2025, 2026 and 2027. DRTT one year forecast. DIRTT Environmental Solutions stock ...View the latest Durect Corp. (DRRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Their DRRX share price targets range from $27.00 to $41.00. On average, they expect the company's stock price to reach $34.25 in the next twelve months. This suggests a possible upside of 5,194.5% from the stock's current price. View analysts price targets for DRRX or view top-rated stocks among Wall Street analysts. The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.62

Apr 24, 2023 · Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ... DRRX stock recorded 20/30 (67%) green days with 62.91% price volatility over the last 30 days. Based on our DURECT stock forecast, it's now a bad time to buy DRRX stock because it's trading 19.19% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.Constituent Stocks. 11/10/2023 00:31:46 ET. Symbol Name Latest price Chg %Chg. AMPHAmphastar Pharmaceuticals52.4106.990+15.39%DRRXDurect0.5700.043+8.16%ENDPQ ...What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system. Biotech Stock Screener. The top biotech stocks list is updated daily after market close. To find low price biotech stocks, go to biotech stocks under $5. 12/1/2023. To get intraday penny stocks update (every 5-10 minutes), please signup for a free account. Symbol.

Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.Durect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...See historical performance and comparison. View Valuation. Research DURECT's (Nasdaq:DRRX) stock price, latest news & stock analysis. Find everything …DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ...The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to DRRX in the past 3 months. Our stock price may be volatile, and your investment in our common stock could decline in value. The market prices for securities of healthcare companies in ...DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real...

(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...

The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...

Dec 1, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00. Forecast . Price target. 19.38 0.00 0.00%. The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 4 analysts giving stock ratings to DRRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreDRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372.Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Comtech Telecommunications Corp. -0.84%. $335.84M. GSAT | Complete Globalstar Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...The forecasts range from a low of $32.32 to a high of $38.85. ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K ... The firm increased its portfolio allocation in DRRX by 30. ...View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business.

Jun 7, 2023 · On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trial Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00. Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ... Instagram:https://instagram. ionq stock price prediction 2025best server hosting minecrafthospital corporation of america stocknasdaq avtx It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence. ebet newsoptions action Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to ...Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ... how to calculate dividend yield 1.82%. $205.6M. Acura Pharmaceuticals Inc. 0.00%. $66. DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.